| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3897852 | Urology | 2016 | 7 Pages |
Abstract
sGC activator seems to be a promising alternative to treat benign prostatic hyperplasia because it increases cGMP levels even when sGC is oxidized.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fabiano B. Calmasini, Eduardo C. Alexandre, Fabio Henrique Silva, Gilberto De Nucci, Edson Antunes, Carlos A. D'Ancona, FabÃola Z. Mónica,